Provided by Tiger Trade Technology Pte. Ltd.

Maze Therapeutics

24.89
+0.07000.28%
Volume:602.77K
Turnover:14.98M
Market Cap:1.38B
PE:-9.89
High:25.99
Open:25.14
Low:24.65
Close:24.82
52wk High:53.65
52wk Low:22.01
Shares:55.25M
Float Shares:37.25M
Volume Ratio:4.58
T/O Rate:1.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5172
EPS(LYR):-3.0510
ROE:-37.35%
ROA:-21.79%
PB:3.03
PE(LYR):-8.16

Loading ...

Sep 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 17, 2026

Major Issues Report

Form 8-K - Current report
Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 11, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2026

Major Issues Report

Form 8-K - Current report
Aug 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jul 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 10, 2026

Major Issues Report

Form 8-K - Current report
Jun 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 22, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]